Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M31,069Revenue $M628Net Margin (%)-116.9Altman Z-Score10.0
Enterprise Value $M31,016EPS $-3.1Operating Margin %-101.7Piotroski F-Score2
P/E(ttm)--Beneish M-Score0.1Pre-tax Margin (%)-116.9Higher ROA y-yN
Price/Book34.610-y EBITDA Growth Rate %--Quick Ratio3.4Cash flow > EarningsY
Price/Sales48.35-y EBITDA Growth Rate %--Current Ratio3.5Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-32.2Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-69.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M244ROIC % (ttm)-118.0Gross Margin Increase y-yY

Gurus Latest Trades with VRTX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VRTXGeorge Soros 2015-06-30 Sold Out -0.07%$116.43 - $135.82
($125.88)
$ 127.201%Sold Out0
VRTXKen Fisher 2015-06-30 Reduce$116.43 - $135.82
($125.88)
$ 127.201%Reduce 0.18%4,378
VRTXVanguard Health Care Fund 2015-03-31 Reduce-0.08%$107.88 - $134.25
($119.81)
$ 127.206%Reduce 2.80%9,533,911
VRTXGeorge Soros 2015-03-31 Buy 0.07%$107.88 - $134.25
($119.81)
$ 127.206%New holding56,912
VRTXKen Fisher 2015-03-31 Add$107.88 - $134.25
($119.81)
$ 127.206%Add 0.18%4,386
VRTXVanguard Health Care Fund 2014-12-31 Reduce-0.58%$101.1 - $120.78
($112.61)
$ 127.2013%Reduce 16.93%9,808,860
VRTXKen Fisher 2014-09-30 Reduce$84.74 - $113.9
($94.97)
$ 127.2034%Reduce 31.99%4,593
VRTXVanguard Health Care Fund 2014-06-30 Add0.04%$62.44 - $94.68
($70.13)
$ 127.2081%Add 1.54%11,807,500
VRTXGeorge Soros 2014-06-30 Sold Out -0.01%$62.44 - $93.77
($69.73)
$ 127.2082%Sold Out0
VRTXKen Fisher 2014-06-30 Buy $62.44 - $93.77
($69.73)
$ 127.2082%New holding6,753
VRTXVanguard Health Care Fund 2014-03-31 Add0.13%$67.8 - $85.48
($79.08)
$ 127.2061%Add 5.89%11,628,500
VRTXGeorge Soros 2014-03-31 Buy 0.01%$67.8 - $85.48
($79.17)
$ 127.2061%New holding10,000
VRTXVanguard Health Care Fund 2013-12-31 Add0.88%$60.18 - $77.83
($69.45)
$ 127.2083%Add 54.06%10,981,500
VRTXVanguard Health Care Fund 2013-09-30 Add0.29%$74.53 - $88.51
($79.62)
$ 127.2060%Add 19.00%7,127,997
VRTXVanguard Health Care Fund 2013-06-30 Add1.05%$52.6 - $85.6
($73.64)
$ 127.2073%Add 140.58%5,990,000
VRTXNWQ Managers 2013-06-30 Sold Out -0.09%$52.6 - $85.6
($73.64)
$ 127.2073%Sold Out0
VRTXVanguard Health Care Fund 2013-03-31 Add0.05%$43.65 - $54.97
($48.01)
$ 127.20165%Add 10.97%2,489,800
VRTXNWQ Managers 2013-03-31 Reduce-0.02%$41.9 - $54.97
($47.91)
$ 127.20165%Reduce 23.44%191,032
VRTXGeorge Soros 2012-09-30 Sold Out -0.09%$48.38 - $59.07
($53.5)
$ 127.20138%Sold Out0
VRTXJoel Greenblatt 2012-09-30 Sold Out -0.08%$48.38 - $59.07
($53.5)
$ 127.20138%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VRTX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


VRTX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BOGER JOSHUA SDirector 2015-09-02Sell10,400$125.850.91view
Lee YuchunDirector 2015-09-01Sell1,125$125.41.27view
BOGER JOSHUA SDirector 2015-08-26Sell10,400$124.711.83view
BOGER JOSHUA SDirector 2015-08-19Sell10,400$139.93-9.25view
BOGER JOSHUA SDirector 2015-08-12Sell10,400$135.83-6.51view
BOGER JOSHUA SDirector 2015-08-05Sell10,400$141.26-10.1view
Arbuckle Stuart AEVP\Chief Commercial Officer 2015-08-05Sell19,828$141.28-10.11view
SACHS BRUCE IDirector 2015-08-04Sell10,000$140.13-9.38view
MCGLYNN MARGARET GDirector 2015-08-03Sell12,500$137.28-7.5view
Silva Paul MSVP & Corp Controller 2015-07-30Sell860$128.96-1.53view

Quarterly/Annual Reports about VRTX:

    News about VRTX:

    Articles On GuruFocus.com
    Lee Ainslie Adds 90 New Stocks to His Portfolio Within the First Quarter May 20 2015 
    Analysts Confident That Vertex Pharmaceuticals' CF Drug Will Receive FDA Approval May 13 2015 
    Fate Of Cystic Fibrosis Drug By Vertex Is Now Dependent On FDA Approval May 13 2015 
    J.P. Morgan Chimes In With Ratings On BioTech Stocks Jan 06 2015 
    William Blair’s Top BioPharmaceutical Stock Picks for Q1 2015 Dec 23 2014 
    Weekly CFO Sells Highlight: Texas Instruments Inc, Royal Caribbean Cruises Ltd, Vertex Pharmaceutica Nov 09 2014 
    Weekly CFO Sells Highllight: Facebook Inc, Vertex Pharmaceuticals Inc, Nike Inc. Oct 05 2014 
    Vanguard Health Care Fund Buys Vertex Pharmaceuticals, Zoetis Inc, , Sells Cerner Corporation, AbbVi Aug 02 2013 
    Weekly Guru Bargains Highlights: MBI, VRTX, GRPN, PBI, PC Dec 16 2012 
    WEEKLY CFO SELLS HIGHLIGHT: AKRX, FIO, OVRL, VRTX Oct 21 2012 

    More From Other Websites
    Biogen And Gilead Sciences Catch The Eye Of Short Sellers Aug 27 2015
    4 Biotechs Piper Jaffray Is Buying On The Pullback Aug 26 2015
    Here's who Mass. biotechs are supporting in recent elections (BBJ DataCenter) Aug 26 2015
    Biotechs rally back Aug 24 2015
    Biotech Stocks Recover From Early-Morning Flash Crash Aug 24 2015
    How Does Vertex Compare to Its Peers? Aug 21 2015
    Vertex Stock Rises after 2Q15 Results Announcement Aug 21 2015
    Will Orkambi Be a Game Changer for Vertex? Aug 21 2015
    Vertex Awards Two Boston Public High School Students the Vertex Science Leaders Scholarship to the... Aug 19 2015
    In the shadow of Vertex, small cystic fibrosis-focused biotechs thrive Aug 17 2015
    Biotech still great growth sector: Pro Aug 14 2015
    What Drove Vertex’s Revenue in 2Q15? Aug 11 2015
    Vertex Reports 2Q15 Revenues of $166.1 Million Aug 11 2015
    What Led Large-Cap Stocks to Outperform Mid and Small Caps? Aug 11 2015
    ​Here’s why Vertex fell short on its job-creation vows to the city Aug 11 2015
    VERTEX PHARMACEUTICALS INC / MA Financials Aug 11 2015
    Key for Investors: How Are Biotech Stocks Trending? Aug 10 2015
    Biotech Stocks Rise Due to a Stable Market: July 31 Week Aug 10 2015
    The Zacks Analyst Blog Highlights: Amgen, Vertex, Regeneron, Baxalta and VIVUS - Press Releases Aug 06 2015
    VERTEX PHARMACEUTICALS INC / MA Files SEC form 10-Q, Quarterly Report Aug 04 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK